{"protocolSection":{"identificationModule":{"nctId":"NCT05884762","orgStudyIdInfo":{"id":"35RC22_9743_YUWIN-Stroke"},"secondaryIdInfos":[{"id":"2023-A01150-45","type":"REGISTRY","domain":"IDRCB"}],"organization":{"fullName":"Rennes University Hospital","class":"OTHER"},"briefTitle":"earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke","officialTitle":"earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke","acronym":"YUWIN-Stroke"},"statusModule":{"statusVerifiedDate":"2023-12","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-12-31","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2025-04-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-04-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-05-23","studyFirstSubmitQcDate":"2023-05-23","studyFirstPostDateStruct":{"date":"2023-06-01","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-12-14","lastUpdatePostDateStruct":{"date":"2023-12-20","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Rennes University Hospital","class":"OTHER"},"collaborators":[{"name":"Fondation de l'Avenir","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The aim of this study is to evaluate the effect of early rehabilitation treatment by electroencephalographic neurofeedback on upper limb motor function after stroke.\n\nResearchers will compare :\n\nInterventional group: electroencephalographic neurofeedback + traditional reference rehabilitation programme Control group: SHAM electroencephalographic neurofeedback + traditional reference rehabilitation programme"},"conditionsModule":{"conditions":["Stroke","Stroke Hemorrhagic","Stroke, Ischemic","Stroke Rehabilitation","Brain Infarction"],"keywords":["Stroke","Rehabilitation","neurofeedback","Upper Limb"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","maskingDescription":"The occupational therapist who will include and do the sessions will be open. The assessors who will test motor functions during the assessments will be blind","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":40,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Interventional group","type":"EXPERIMENTAL","description":"electroencephalographic neurofeedback + traditional reference rehabilitation programme","interventionNames":["Other: electroencephalographic neurofeedback"]},{"label":"Control group","type":"SHAM_COMPARATOR","description":"SHAM electroencephalographic neurofeedback + traditional reference rehabilitation programme","interventionNames":["Other: SHAM electroencephalographic neurofeedback"]}],"interventions":[{"type":"OTHER","name":"electroencephalographic neurofeedback","description":"The patient is installed in a quiet, isolated room in the Physical Medicine and Rehabilitation Department. The patient sits comfortably in front of a computer. A nurse or a rehabilitator installs the EEG headset and places gel in the electrodes (x32). Connecting the amplifier and interface. Checking the correct positioning and contact of the electrodes (impedance).\n\n* Calibration phase at rest.\n* Working phase: the sessions last 24 minutes. The patient will be asked to concentrate on the affected arm, and to imagine a movement of this arm, to feel the sensations, without any real movement of the arm.\n\n  * In the Neurofeedback group, the patient will receive visual feedback of a virtual hand moving on a computer screen in front of him/her, depending on his/her brain activations. He will also receive haptic feedback (vibrations) in the flexor muscles of his wrist.","armGroupLabels":["Interventional group"]},{"type":"OTHER","name":"SHAM electroencephalographic neurofeedback","description":"The patient is installed in a quiet, isolated room in the Physical Medicine and Rehabilitation Department. The patient sits comfortably in front of a computer. A nurse or a rehabilitator installs the EEG headset and places gel in the electrodes (x32). Connecting the amplifier and interface. Checking the correct positioning and contact of the electrodes (impedance).\n\n* Calibration phase at rest.\n* Working phase: the sessions last 24 minutes. The patient will be asked to concentrate on the affected arm, and to imagine a movement of this arm, to feel the sensations, without any real movement of the arm.\n\n  * In the SHAM group, the visual feedback and haptic feedback are randomly generated","armGroupLabels":["Control group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Measurement of motor impairment by the Fugl-Meyer Assesment - Upper Extremity","description":"Measurement of motor impairment by the Fugl-Meyer Assesment - Upper Extremity","timeFrame":"28 days"}],"secondaryOutcomes":[{"measure":"Changes in ACTIVE RANGE OF MOTION (CxA) composite score","description":"Changes in ACTIVE RANGE OF MOTION (CxA) composite score","timeFrame":"28 days"},{"measure":"Changes in ACTIVE RANGE OF MOTION (CxA) composite score","description":"Changes in ACTIVE RANGE OF MOTION (CxA) composite score","timeFrame":"3 months"},{"measure":"Changes in Action Research Arm Test (ARAT) score","description":"Changes in Action Research Arm Test (ARAT) score","timeFrame":"28 days"},{"measure":"Changes in Action Research Arm Test (ARAT) score","description":"Changes in Action Research Arm Test (ARAT) score","timeFrame":"3 months"},{"measure":"Changes in force emitted (in kg) during a palmar grip (JAMAR)","description":"Changes force emitted (in kg) during a palmar grip (JAMAR)","timeFrame":"28 days"},{"measure":"Changes in force emitted (in kg) during a palmar grip (JAMAR)","description":"Changes force emitted (in kg) during a palmar grip (JAMAR)","timeFrame":"3 months"},{"measure":"Progression in Evaluation of the Motor activiy Log (MAL)","description":"Progression in Evaluation of the Motor activiy Log (MAL)","timeFrame":"28 days"},{"measure":"Progression in Evaluation of the Motor activiy Log (MAL)","description":"Progression in Evaluation of the Motor activiy Log (MAL)","timeFrame":"3 months"},{"measure":"Progression in The Composite Functional Independence Scale (MIF)","description":"Progression in The Composite Functional Independence Scale (MIF)","timeFrame":"28 days"},{"measure":"Progression in The Composite Functional Independence Scale (MIF)","description":"Progression in The Composite Functional Independence Scale (MIF)","timeFrame":"3 months"},{"measure":"Progression in The Stroke Impact Scale (SIS)","description":"Progression in The Stroke Impact Scale (SIS)","timeFrame":"28 days"},{"measure":"Progression in The Stroke Impact Scale (SIS)","description":"Progression in The Stroke Impact Scale (SIS)","timeFrame":"3 months"},{"measure":"Brain activity measured by electroencephalogram : improvement in cerebral activations in target zones","description":"Brain activity measured by electroencephalogram : improvement in cerebral activations in target zones","timeFrame":"28 days"},{"measure":"Brain datas (fMRI activity and CST tractography)","description":"Brain datas (fMRI activity and CST tractography)","timeFrame":"28 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Unilateral ischaemic or haemorrhagic stroke\n* Adult (18-80 years), both sexes\n* Stroke \\< 3 weeks\n* Upper limb deficit defined by Shoulder Abduction Finger Extension score \\<5 on day 3 of stroke; i.e., patients predicted to have incomplete recovery\n* No participation-limiting comprehension problems\n* With or without homonymous lateral hemianopia; with or without visuospatial hemineglect\n* Free, informed and written consent signed by the patient or a member of the patient's family (in the case of a patient who is able to understand the information and give consent but has motor difficulties resulting in an invalid signature).\n* Affiliated to french social security\n\nExclusion Criteria:\n\n* Ischemic or hemorrhagic brain stem and/or cerebellum involvement\n* Multiple strokes\n* Stroke \\< 1 week; in order not to be deleterious by starting active rehabilitation too early after immediate stroke\n* Aphasia with major comprehension impairment\n* Contraindication to MRI\n\n  * pacemaker or implantable defibrillator,\n  * neurosurgical clips,\n  * cochlear implants,\n  * intra-orbital or encephalic metallic foreign bodies,\n  * stents placed less than 4 weeks ago and osteosynthesis devices placed less than 6 weeks ago,\n  * claustrophobia.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"LOÃC JACOB","role":"CONTACT","phone":"0299282555","email":"loic.jacob@chu-rennes.fr"}],"overallOfficials":[{"name":"Simon BUTET, MD","affiliation":"Rennes CHU","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Rennes Chu","city":"Rennes","zip":"35000","country":"France","contacts":[{"name":"Simon BUTET, MD","role":"CONTACT","phone":"0299284218","email":"simon.butet@chu-rennes.fr"},{"name":"Simon BUTET, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":48.11198,"lon":-1.67429}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000083302","term":"Hemorrhagic Stroke"},{"id":"D000007238","term":"Infarction"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000007511","term":"Ischemia"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000009336","term":"Necrosis"},{"id":"D000002545","term":"Brain Ischemia"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M9972","name":"Infarction","asFound":"Infarction","relevance":"HIGH"},{"id":"M2405","name":"Hemorrhagic Stroke","asFound":"Stroke Hemorrhagic","relevance":"HIGH"},{"id":"M21995","name":"Brain Infarction","asFound":"Brain Infarction","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Ischemic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}